Key facts
- This page summarizes Mark Oldakowski's Form 4 filing for Bionano Genomics, Inc. (BNGO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2026, 20:51.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Additional SEC filing notes
Footnote F1
The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.